| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G/A |
| 13 Nov 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On November 11, 2026, the Board of Directors (the “Board”) of iRhythm Holdings, Inc. (the “Company”) adopted the iRhythm Deferred Compensation Plan (the “Plan”), to be sponsored by the Company and providing for participation by the Compa... |
| 12 Nov 2026 | SCHEDULE 13G/A |
| 12 Nov 2026 |
8-K: Regulation FD Disclosure; Other Events
SAN FRANCISCO, November 11, 2026 - iRhythm Holdings, Inc. (Nasdaq: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease, today announced that on November 10, 20... |
| 05 Nov 2026 | 10-Q |
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
SAN FRANCISCO, November 5, 2026 -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company with a mission to create trusted solutions that detect, predict, and prevent disease, today reported financial results for th... |
| 13 Oct 2026 | SCHEDULE 13G/A |
| 05 Oct 2026 |
8-K: Regulation FD Disclosure
iRhythm Completes Acquisition of VitalConnect, Expanding Its Cardiac Monitoring Platform Across Ambulatory, Inpatient and Hospital-to-Home Care Combination broadens iRhythm’s cardiac monitoring portfolio, advances its multi-vitals stra... |
| 22 Sep 2026 |
8-K: Regulation FD Disclosure
As previously announced, on August 5, 2026, iRhythm Holdings, Inc., a Delaware corporation (the “Company”), iRhythm Technologies, Inc., a Delaware corporation and a direct wholly owned subsidiary of the Company (“Acquirer”), Project Vess... |
| 03 Sep 2026 |
Form 4: Wilson Daniel G., Chief Financial Officer
Sold 773 shares ($94.2K) |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 | SCHEDULE 13G |
| 13 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On August 11, 2026, Brian Yoor notified iRhythm Holdings, Inc. (the “Company”) of his decision to resign from his position as a member of the Board of Directors of the Company (the “Board”) and as a member and chair of the Audit Committe... |
| 11 Aug 2026 |
Form 4: Blackford Quentin S., Director
Received 48,534 shares as a grant or award · Sold 26,859 shares ($3.35M) |
| 11 Aug 2026 |
Form 4: Murphy Patrick Michael, CBO and CLO
Received 13,589 shares as a grant or award · Sold 7,093 shares ($884K) |
| 11 Aug 2026 |
Form 4: Patterson Chad, CHIEF COMM & PRODUCT OFFICER
Received 13,589 shares as a grant or award · Sold 7,093 shares ($884K) |
| 11 Aug 2026 |
Form 4: Shrishrimal Sumi, EVP, Chief Risk Officer
Received 9,706 shares as a grant or award · Sold 5,372 shares ($670K) |
| 11 Aug 2026 |
Form 4: Turakhia Minang, CHIEF MED/SCI OFCR EVP ADVTECH
Received 13,589 shares as a grant or award · Sold 7,093 shares ($884K) |
| 06 Aug 2026 | 10-Q |
| 06 Aug 2026 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities
EXHIBIT 2.1 AGREEMENT AND PLAN OF MERGER by and among IRHYTHM TECHNOLOGIES, INC., a Delaware corporation, IRHYTHM HOLDINGS, INC., a Delaware corporation, PROJECT VESSEL MERGER SUB, INC., a Delaware corporation, VITAL CONNECT, INC., a Del... |
Loading...